Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-24-119152·Aprea Therapeutics, Inc.
Schedule 13G ownership disclosure
APREA THERAPEUTICS INC
Common stock, par value $0.001 per share · CUSIP: 03836J201
Event date: 2024-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nantahala Capital Management, LLC
Shares: 411,520.00 · Class: 7.2995%
- Wilmot B. Harkey
Shares: 411,520.00 · Class: 7.2995%
- Daniel Mack
Shares: 411,520.00 · Class: 7.2995%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-119152
- Form type
- SCHEDULE 13G
- Filer
- Aprea Therapeutics, Inc.
- CIK
- CIK 1781983
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership